Kenneth J. Pienta

Active 1984–2025

323
Papers
79,208
Citations
141
h-index
310
i10-index

Citations

Citations per year for Kenneth J. Pienta1967: 2 citations1978: 1 citations1985: 1 citations1986: 2 citations1987: 2 citations1988: 7 citations1989: 13 citations1990: 24 citations1991: 22 citations1992: 16 citations1993: 36 citations1994: 46 citations1995: 44 citations1996: 43 citations1997: 48 citations1998: 61 citations1999: 70 citations2000: 79 citations2001: 96 citations2002: 178 citations2003: 248 citations2004: 333 citations2005: 343 citations2006: 420 citations2007: 498 citations2008: 654 citations2009: 700 citations2010: 716 citations2011: 753 citations2012: 748 citations2013: 853 citations2014: 887 citations2015: 854 citations2016: 859 citations2017: 943 citations2018: 1,010 citations2019: 2,706 citations2020: 2,879 citations2021: 2,815 citations2022: 2,115 citations2023: 1,522 citations2024: 2,371 citations2025: 1,100 citations2026: 33 citations1968–1977: no citations, so these years are not shown1979–1984: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 9,754 citing papers, 31.3% of this breakdownChina: 3,672 citing papers, 11.8% of this breakdownUnited Kingdom: 1,851 citing papers, 5.9% of this breakdownGermany: 1,461 citing papers, 4.7% of this breakdownItaly: 1,351 citing papers, 4.3% of this breakdownCanada: 1,255 citing papers, 4% of this breakdownFrance: 926 citing papers, 3% of this breakdownJapan: 887 citing papers, 2.8% of this breakdownAustralia: 868 citing papers, 2.8% of this breakdownNetherlands: 795 citing papers, 2.6% of this breakdownSpain: 649 citing papers, 2.1% of this breakdownIndia: 629 citing papers, 2% of this breakdown
0%31.3%Other 22.7%

Fields

  • Medicine49.6%
  • Biochemistry, Genetics and Molecular Biology36.2%
  • Immunology and Microbiology7.1%
  • Engineering1.8%
  • Computer Science0.7%
  • Chemistry0.6%
  • Other4%

Topics

  • Prostate Cancer Treatment and Research7.7%
  • Cancer Cells and Metastasis4.2%
  • Prostate Cancer Diagnosis and Treatment3.3%
  • Cancer Genomics and Diagnostics3.2%
  • Epigenetics and DNA Methylation2.7%
  • Immune cells in cancer1.9%
  • Other77%

Coauthors

All papers

Open in search
  1. Integrative Clinical Genomics of Advanced Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Victor E. Reuter, Anuradha Gopalan, Jianjiong Gao, Massimo Loda, Rosina T. Lis, Michaela Bowden, Stephen Balk, Glenn C. Gaviola, Carrie Sougnez, Manaswi Gupta, Evan Y. Yu, Elahe A. Mostaghel, Heather H. Cheng, Hyojeong Mulcahy, Lawrence D. True, Stephen R. Plymate, Heidi Dvinge, Roberta Ferraldeschi, Penny Flohr, Susana Miranda, Zafeiris Zafeiriou, Nina Tunariu, Joaquı́n Mateo, Raquel Pérez-López, Francesca Demichelis, Brian D. Robinson, Marc Schiffman, David M. Nanus, Scott T. Tagawa, Alexandros Sigaras, Kenneth Eng, Olivier Elemento, Andrea Sboner, Elisabeth I. Heath, Howard I. Scher, Kenneth J. Pienta, Philip W. Kantoff, Johann S. de Bono, Mark A. Rubin, Peter S. Nelson, Levi A. Garraway, Charles L. Sawyers, Arul M. Chinnaiyan - Cell 2015 cited by 3,701

  2. Updating the Definition of Cancer

    Authors: , , , , , - Molecular Cancer Research 2023 cited by 591

  3. Targeting the tumour stroma to improve cancer therapy

    Authors: , , - Nature Reviews Clinical Oncology 2018 cited by 1,098

  4. Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2020 cited by 1,140

  5. The mutational landscape of lethal castration-resistant prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2012 cited by 2,607

  6. Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment

    Authors: , , - Molecular Cancer 2019 cited by 465

  7. Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2017 cited by 756

  8. Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2011 cited by 1,020

  9. The polycomb group protein EZH2 is involved in progression of prostate cancer

    Authors: , , , , , , , , , , , - Nature 2002 cited by 2,725

  10. Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters

    Authors: , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 762

  11. Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer

    Authors: , , , , , , , , , - Clinical Cancer Research 2008 cited by 2,183

  12. A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18 F-DCFPyL in Prostate Cancer Patients (OSPREY)

    Authors: , , , , , , , , , , , , , , , , - The Journal of Urology 2021 cited by 372

  13. Comprehensive evaluation of methods for small extracellular vesicles separation from human plasma, urine and cell culture medium

    Authors: , , , , , , , , , , , , , , - Journal of Extracellular Vesicles 2020 cited by 250

  14. Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer

    Authors: , , , , , , , , , , , , - Investigational New Drugs 2012 cited by 399

  15. Activating ESR1 mutations in hormone-resistant metastatic breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2013 cited by 1,158

  16. Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer

    Authors: , , , , , , , , , , , , , , , - Science 2005 cited by 3,865

  17. Characterization of extracellular vesicles and synthetic nanoparticles with four orthogonal single‐particle analysis platforms

    Authors: , , , , , , , , , , , , , , , , - Journal of Extracellular Vesicles 2021 cited by 220

  18. Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maximillian Diehn, Søren M. Bentzen, Steven Joniau, Friedl Vanhaverbeke, Gert De Meerleer, Emmanuel S. Antonarakis, Tamara L. Lotan, Alejandro Berlín, Shankar Siva, Piet Ost, Phuoc T. Tran - Journal of Clinical Oncology 2022 cited by 243

  19. Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2023 cited by 103

  20. CCL2 and Interleukin-6 Promote Survival of Human CD11b+ Peripheral Blood Mononuclear Cells and Induce M2-type Macrophage Polarization

    Authors: , , , , , - Journal of Biological Chemistry 2009 cited by 573

  21. Integrative Clinical Genomics of Advanced Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Victor E. Reuter, Anuradha Gopalan, Jianjiong Gao, Massimo Loda, Rosina T. Lis, Michaela Bowden, Stephen Balk, Glenn C. Gaviola, Carrie Sougnez, Manaswi Gupta, Evan Y. Yu, Elahe A. Mostaghel, Heather H. Cheng, Hyojeong Mulcahy, Lawrence D. True, Stephen R. Plymate, Heidi Dvinge, Roberta Ferraldeschi, Penny Flohr, Susana Miranda, Zafeiris Zafeiriou, Nina Tunariu, Joaquı́n Mateo, Raquel Pérez-López, Francesca Demichelis, Brian D. Robinson, Andrea Sboner, Marc Schiffman, David M. Nanus, Scott T. Tagawa, Alexandros Sigaras, Kenneth Eng, Olivier Elemento, Andrea Sboner, Elisabeth I. Heath, Howard I. Scher, Kenneth J. Pienta, Philip W. Kantoff, Johann S. de Bono, Mark A. Rubin, Peter S. Nelson, Levi A. Garraway, Charles L. Sawyers, Arul M. Chinnaiyan - Cell 2015 cited by 591

  22. Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis

    Authors: , , , , , , , , , , , , , , , , , - Nature Communications 2013 cited by 414

  23. Identification of Targetable FGFR Gene Fusions in Diverse Cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2013 cited by 738

  24. Classifying the evolutionary and ecological features of neoplasms

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature reviews. Cancer 2017 cited by 453